Newsroom.

Teaneck, NJ– GC Biopharma USA, the commercial operations and distribution company of GC Biopharma, has announced the appointment of Christina Iskandar to its senior leadership team as Associate Director of Human Resources. Christina comes to GC Biopharma USA with a strong background in talent management with best-in-class employers within the healthcare industry, including GE Healthcare and AbbVie.

Lisa Betts, VP of Operations at GC Biopharma USA, says the following about Christina: “She has all the right experience to help us establish a culture of growth and support. This is what you would expect from an HR lead. But we also saw in Christina a passion for helping people, and a commitment to transparency that perfectly aligned with the values of our US leadership team and GC Biopharma as a whole.”

Christina is excited to join the GC Biopharma USA team at such an early stage. She notes: “GC Biopharma has an amazing history and culture globally. I’m excited to help establish our US culture in a way that connects to the core values and resources of our parent company but allows us to stand out on our own. I can step in and make an impact right away. I can more easily develop processes that set us apart as a company and help us attract and retain top talent. That’s exciting.”

She adds: “Because we are a relatively small team right now, it allows us to operate like family—supporting one another to overcome obstacles, no matter what’s going on.”

The addition of Christina Iskandar to the US leadership team reinforces GC Biopharma's vision of establishing excellence within its US-based operations.

About GC Biopharma

GC Biopharma USA, headquartered in Teaneck, NJ, established its sales, marketing, and business operations in 2018 to serve customers and patients throughout the US. Our foundation is built on the expertise of our parent company GC Biopharma, a leading biopharmaceutical company delivering plasma therapies and vaccines worldwide for more than 50 years. With GC Biopharma USA, GC Biopharma will further extend its footprint, bringing its expertise and legacy to the US.

This press release may contain forward-looking statements that express the current beliefs and expectations of the management at GC Biopharma and GC Biopharma USA. Such views do not represent any guarantee by either entity or its government of future performance and involve known and unknown risks, uncertainties, and other factors. GC Biopharma and GC Biopharma USA undertake no obligation to update or revise any forward-looking statement contained in this press release or any other forward-looking statements they may make, except as required by law or stock exchange rule.

©2024 GC Biopharma USA, Inc. All rights reserved.
All trademarks are the property of their respective owners.
ALY-C-0075    11/2024